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ABSTRACT  
 
Aim: The aim of this work is to test if three single nucleotide polymorphisms (SNPs) implicated in 
glutamate homeostasis or signalling and cellular survival are associated with birth condition. 
Methods: This study is drawn from the Avon Longitudinal Study of Parents and Children. 7611 
term infants were genotyped and patient outcome data retrieved from routine medical records. 
Exposure measures were the presence of one or more minor alleles in one of 3 SNPs (rs2284411, 
rs2498804, rs1835740). The primary outcome was the need for resuscitation at birth.  
Results: For SNP rs1835740, infants homozygous for the minor allele compared to wild-type were 
more likely to need resuscitation (9.2% vs. 7.0%, p=0.041) while the odds ratio for resuscitation 
was associated with each increasing minor allele (OR 1.17 (1.01 to 1.35)). Population attributable 
risk fraction was 6.5%. There was no evidence that the other two SNPs investigated were 
associated with birth condition. 
Conclusions: We have tested three candidate SNPs to measure any association with birth 
condition. The study revealed that the rs1835740 was associated with the need for resuscitation 
and Apgar scores, with a substantial population impact. 
 
Key Words: Asphyxia Neonatorum, Brain, Cohort Studies, Hypoxia-Ischemia, Glutamate, 
Polymorphism 
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KEY NOTES 
 We have tested three candidate SNPs to measure any association with birth condition. 
 There was evidence that one (rs1835740) was associated with the need for resuscitation 
and Apgar scores, with a substantial population impact. 
 This is some of the first in vivo evidence implicating glutamate in perinatal asphyxia. 
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INTRODUCTION 
Most infants tolerate the birth process well, but ~7% require some degree of resuscitation and 
~0.5% of all births go on to develop immediate signs of brain damage.(1) We(1) and others(3) 
have been attempting to quantify the effect and wider impact of physiological compromise during 
the birth process. It is well recognized that infants born in poor condition, and in particular those 
who go on to develop signs of neurological impairment shortly after birth, have increased risk of 
movement disorders (cerebral palsy) and intellectual disability.(4) The outcomes is also 
devastating for the patients’ family and society.(5,6) We have shown that the neurological 
impairment persist through childhood(1) into adulthood.(2) Our work has also suggested important 
effects on social measures of outcome such as income, education and marriage.(7) Importantly, 
we have reported long-term impacts in infants who only required  brief life support at birth and had 
no noticeable problems in the neonatal period,(1,7) consistent with the hypothesis of a “Continuum 
of Reproductive Casualty.”(8) 
 
Hypoxic events are frequently associated with birth complications.(9) It has been proposed that the 
major excitatory neurotransmitter glutamate and its receptors play a key role in the neural damage 
that occurs during hypoxic episodes in the developing brain(10). Indeed, glutamate concentration 
has been found to be markedly increased in the cerebrospinal fluid(11) and also in the basal 
ganglia of asphyxiated newborn infants measured in vivo by Magnetic Resonance 
Spectroscopy.(12) While in vivo evidence is limited, single nucleotide polymorphisms (SNPs) 
affecting gene transciption and protein function  in glutamatergic signalling and cell survival 
pathways may play a key role in cerebral recovery after hypoxic events.(13)   
 
In acute ischaemic brain injury in newborns, the primary step leading to excitotoxicity and neuronal 
death is the excessive activation of glutamate receptors, principally the synaptic and GluN2B 
subunit-containing extrasynaptic N-methyl-D-asparate receptors (NMDARs).(13,14) GluN2B is 
highly expressed during the perinatal developmental period and deletions in the GluN2B gene are 
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associated with cognitive disability in children.(15) Intriguingly, the functional polymorphism 
rs2284411 in GluN2R has an impact on susceptibility to neurodevelopmental disorders in 
children.(16) 
The serine/threonine kinase Akt (or protein kinase B, PKB) mediates neuronal cell survival in 
response to growth factors in the developing central nervous system(17) and involved in group I 
metabotropic glutamate receptor-linked signalling.(18)  Akt has been reported to enhance cell 
survival in neurones by blocking induction of apoptosis.(19)  The SNP rs2498804 in the Akt gene 
have been found to impair Akt function resulting in increased apoptosis.(21) In patients with 
schizophrenia who were born after obstetric complications this variant was more common, 
suggesting that this SNP may increase foetal vulnerability to hypoxia.(20) 
SNP rs1835740, is located between astrocyte elevated gene 1 (AEG1)(21) and plasma glutamate 
carboxypeptidase (PGCP).(22) AEG1 down regulates the major glutamate transporter, the 
excitatory amino-acid transporter-2 (EAAT2), in the central nervous system (CNS) and PGCP is 
involved in glutamate synthesis.  rs1835740 was demonstrated  to be a cis-acting regulator of 
AEG-1 and the risk A allele (in forward orientation T allele) was associated with higher expression 
levels of AEG1 and  the development of migraine(22) and cluster headaches, suggesting a link 
between the rs1835740 variant and impaired regulation of glutamate levels in the CNS.(20,21) 
 
We hypothesise that these functional SNPs affecting glutamatergic signalling, homeostasis and 
cell survival in the CNS may influence infants’ susceptibility to the birth process and subsequent 
development of neurological impairment. Identification of a SNP related to birth condition could 
provide both insight into presumed pathophysiological pathways, as well as a marker to assess the 
true impact of perinatal asphyxia at a population level.  
 
 
PATIENTS AND METHODS 
Cohort selection 
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This study is drawn from the Avon Longitudinal Study of Parents and Children (ALSPAC), an on-
going study containing data on over 14,000 infants(23) or which there were 7611 term (36+0 to 42+6 
weeks gestation) infants who were genotyped using the Illumina HumanHap550 quad genome-
wide SNP genotyping platform (Illumina UK, Little Chesterford, UK).(24) Further information about 
the study can be found on the ALSPAC website which contains details of all the data that is 
available through a fully searchable data dictionary [http://www.bris.ac.uk/alspac/researchers/data-
access/data-dictionary/]. Within the SNPs measured by the ALSPAC cohort were 3 potential 
functional SNPs directly measured in these pathways of interest. 
Data on cohort members have been retrieved from routine medical records. Ethical approval for 
the study was obtained from the ALSPAC Law and Ethics Committee and the Local Research 
Ethics Committees. 
Gene Data 
Exposure measures were the presence of one or more minor alleles in one of three SNPs 
(rs2284411, rs2498804, rs1835740; Table 1) proposed to modify the association between hypoxic 
stress and neuronal injury.  
Outcome measures 
The primary outcome, consistent with our previous work in poor condition at birth,(1) was (i) the 
need for resuscitation at birth. This was defined as the need for positive pressure respiratory 
support using a face mask or endotrachael tube; and/or cardiac compressions at birth.  Two 
secondary measures of birth condition, also consistent with our previous work(1) were also 
included (ii) Duration of poor birth condition defined as the time to reach an Apgar score of 7-10 (a 
normal score)(25) (taken from Apgars documented at 1, 5 and 10 minutes).(1,2,7) (iii) Hypoxic-
Ischaemic Encephalopathy (HIE). HIE may be defined as “a subnormal level of consciousness or 
seizures, and often accompanied by difficulty with initiating and maintaining respiration and 
depression of tone and reflexes”.(26) In this work, infants were diagnosed if the infant had 
seizures, jitteriness, high pitched cry, hypo- or hypertonia or hyper-reflexia during the neonatal 
period following the need for resuscitation).(1) The demographics of the infants included in the 
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study are described in Table 2. 
 
Statistical Methods 
To assess the association between the individual SNP genotypes and the three outcomes, 
univariable comparisons were performed for each genotype. Logistic or ordinal regression models 
(as appropriate) were then derived to assess the association of each increasing minor-allele with 
the three outcomes. Population attributable risks were calculated from the final logistic regression 
model.  
Four sensitivity analyses were performed to investigate alternative mechanisms for any SNP 
association (e.g. effects on gestational age at birth). In the first the association between the three 
SNPs and resuscitation was adjusted for antenatal (gender, parity, maternal hypertension) and 
then intrapartum factors (gestational age, birth weight, length and head circumference, mode of 
birth and neonatal sepsis). Adjustment for possible confounders was performed by adding the 
variables described above to the models, in blocks of common variables (e.g. antenatal). Ordinal 
variables were tested for linearity and included in the model as linear terms if appropriate. In the 
second sensitivity analyses we investigated if the association between the SNPs and the risk of 
resuscitation was modified if the infant was at higher of risk of poor condition at birth (defined as: 
breech deliveries, emergency caesarean sections, instrumental deliveries, low birth weight (<10th 
centile for gestational age), maternal hypertension).(27) In the third analysis we repeated the 
analysis including all SNPs in a single model, while in the fourth we investigated if any association 
was modified by the infants’ gender.  
All analyses were conducted with Stata 10 software (Stata Corp, TX, USA). All data are presented 
as odds ratio (OR) (95% confidence interval (CI)), mean (SD), mean difference (95% CI), median 
(interquartile range (IQR)), or number (percent). 
 
RESULTS 
There was no evidence that the SNPs measured were not in Hardy-Weinberg equilibrium, nor was 
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there any evidence that any of the SNPs were in linkage disequilibrium with each other (all 
comparisons; p>0.10). In the univariable analysis, there was no evidence that rs2284411 or 
rs2498804 were associated with need for resuscitation, time to a normal Apgar score or 
development of hypoxic-ischemic encephalopathy (Table 3). However, for rs1835740 the need for 
resuscitation (p=0.041) and the time to achieve a normal Apgar score (p=0.020) differed by 
genotype (Table 3). Infants homozygous for the minor allele compared to wild-type were more 
likely to need resuscitation (9.2% vs. 7.0%) and took longer to achieve an Apgar score of 7-10 
(number with low Apgar score beyond 5 minutes; 1.2% vs. 0.7%). There was no clear evidence 
that rs1835740 was associated with the risk of hypoxic-ischaemic encephalopathy. 
In the logistic regression neither rs2284411or rs2498804 were found to be associated with the 
need for resuscitation, time to a normal Apgar score or hypoxic-ischaemic encephalopathy (Table 
4). However, consistent with the univariable analysis, each increasing minor allele of rs1835740 
was associated with increased risk of resuscitation (OR 1.17 (1.01 to 1.35)) and time to achieve a 
normal Apgar score (OR 1.17 (1.03-1.34)), but not with hypoxic-ischaemic encephalopathy (OR 
0.92 (0.49 to 1.75)). A model containing all three SNPs produced near-identical results (e.g. 
rs1835740; OR 1.17 (1.01 to 1.35)). Population attributable risk fractions (PARF) were 3.0% for 
rs2284411, 3.1% for rs2498804 and 6.5% for rs1835740. 
In the sensitivity analysis, adjusting for antenatal or intrapartum factors did not substantially modify 
any relationship seen in the initial model, with no association between 2 of the SNPs (rs2284411, 
rs2498804) and the need for resuscitation (Table 5). The association between rs1835740 and 
resuscitation remained in both the model correcting for antenatal factors (OR 1.17 (1.01-1.35)) and 
antenatal/intrapartum factors (OR 1.18 (1.00-1.38)). There was no evidence that high risk delivery 
modified the relationship between any of these SNPs and the need for resuscitation (rs2284411, 
p=0.657; rs2498804, p=0.958; rs1835740, p=0.401). Using a model with all 3 SNPs in showed no 
substantial difference from the main analysis, with only evidence that rs1835740 was associated 
with the need for resuscitation (OR 1.17 (1.01 to 1.35)), while there was no evidence that gender 
modified any association between the SNPs and the need for resuscitation (all p values greater 
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than 0.5). 
 
DISCUSSION 
In this cohort one of the SNPs, rs1835740, implicated in glutamate homeostasis and signalling 
showed an association with birth condition in both the need for resuscitation and the length of time 
the infant took to achieve a normal Apgar score (Table 3). This is, to our knowledge, the first time a 
functional SNP in the excitatory neurotransmitter pathway has been associated with this important 
perinatal outcome. 
Similarly to the majority of SNPs that have been found to be associated with human complex 
diseases and traits in genome-wide association studies, rs1835740 is located between two genes 
(AEG1 and PGCP). AEG1 and PGCP are involved in glutamate homeostasis (22). Genome-wide 
expression quantitative trait locus (eQTL) analysis in lymphoblastoid cells has indicated that 
s1835740 is a cis-acting regulator of the former gene (22) and the risk allele A is associated with 
higher expression levels of AEG-1. Furthermore, it has been shown that AEG-1 downregulates the 
expression of the glutamate transporter EAAT2 in cultured astrocytes (30). Taking all these 
together, in infants with the A allele the expression level of AEG-1 is likely to be elevated which in 
turn can downregulate EAAT-2 resulting in pathological extracellular glutamate levels and 
increased susceptibility to hypoxia-ischaemiainduced excitotoxicity.(22) 
While the underlying pathological mechanisms are not fully understood, it is plausible that the 
rs1835740 SNP modifies the impact of otherwise physiological levels of hypoxia to produce 
cerebral glutamate concentrations substantial enough to produce clinical depression at birth. 
Alternatively, it may modify the infants’ reaction to a similar hypoxic insult, resulting in central 
respiratory depression and corresponding lower Apgar scores, which then require the infant to 
receive resuscitation. In addition the exact mechanisms of poor birth condition are complex and the 
causal pathways unclear (e.g. meconium stained liquor is likely to represent the outcome of 
asphyxia as much as the cause). It is important to note that the population impact of this SNP 
appears substantial. The population attributable risk fraction estimates the proportion of infants 
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born in poor condition due to these genes, and in this work, a fraction of over 6%, suggests that 
this SNP is the cause of 1:16 infants born in poor condition. The presence of Hardy-Weinberg 
equilibrium in this work suggests the population was not selected prior to birth, or through the 
methodology. We have previously shown that infants who require resuscitation in this cohort go on 
to have lower cognitive scores and school performance(1) as well as increased signs of psychiatric 
disease(4) and so, if causal, this SNP may represent an important cause of childhood morbidity 
although we do not have the power to test later impacts within this study. The strength of our study 
is the use of a population-based sample, with prospectively collected data and robust information 
on potential confounders. The main limitation is the restriction of the genotyping to infants 
classified to be within the ethnicities covered by the HapMap project.(28) While the three SNPs we 
have investigated were all measured directly on the infants we were not able to get data on those 
infants who fell outside the standardising procedure used in the genotyping and so were not able to 
investigate the effect of ethnicity due to the low levels of variance in the population. Given the lack 
of dependencies between the SNPs, adjustment for multiple testing in this a-priori work would 
be over-conservative. Bonferroni correction would propose that a ‘significant’ p-values cut-off of 
<0.017 could be used (instead of 0.05). None of our analyses obtained this level of evidence, and 
this emphases that the association seen in this work may simply be that of chance (false positive 
error) and further work to confirm or refute this is needed. We need to acknowledge that we have 
not adjusted the p-values for multiple testing, as all three SNPs were defined a-priori and are not in 
linkage disequilibrium with each other. Two of the three SNPs (rs2284411 and rs2498804) did not 
show significant association with birth condition, and thus it is likely that they play no role in the 
physiological cascade around birth, or that any functional effect they might have is not measurable 
in this work. However the confidence intervals (for resuscitation and Apgar scores at least) were 
relatively narrow suggesting we are likely to be missing only a small effect of these two other 
SNPs, should one exist. However due to the imprecision in the point estimates it is important not to 
see this work as evidence of no association. Of note, results were identical when the analysis was 
repeated excluding infants born at 36 weeks. 
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This work shows that genetic variation has measurable and potentially important impact on 
perinatal health and the birth process itself, which in turn is associated with poorer cognitive skills, 
psychiatric morbidity and worse pragmatic, social outcomes.(1,2,7) We also know that 
interventions around the birth process can modify this risk, with recent work suggesting risk  
profiling may be of use.(29) Of interest, none of the three SNPs investigated here were associated 
with a higher risk of an emergency LSCS (all p-values >0.5). Non-invasive fetal genotyping is also 
becoming possible with recent technical advances giving the possibility of incorporating important 
SNPs into a risk prediction strategy to reduce perinatal asphyxia by targeted obstetric intervention. 
We have tested 3 candidate SNPs to measure any association with birth condition, and while there 
was no significant association between the SNPs in the GluN2B and Akt1 genes with birth 
condition there was evidence that the rs1835740 was associated with the need for resuscitation 
and Apgar scores, with an imporant population impact. This association was not confounded by 
antenatal or intrapartum factors in a sensitivity analysis. 
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Table 1. SNPs included in the analysis 
 
SNP Location Proposed function 
rs2284411 
(g.13866172C>T) 
Chromosome 12p13.1: 
Glutamate receptor, N-
methyl D-asparate receptor 
subunit 2B (GluN2B) gene 
Affects NMDA receptor 
function by  regulatory 
effects of GluN2B gene 
expression(17). 
rs2498804 
(g.105233095C>A) 
Chromosome 14q32.32: V-
akt murine thymoma viral 
oncogene homolog 1 
(Akt1) gene  
Impairs Akt function, 
resulting in increased 
apoptosis in cancer(29) 
and in multiple 
sclerosis(40). 
rs1835740 
(g.98166913T>C) 
Chromosome 8q22.1 Down regulates glutamate 
transport (EAAT2) and 
promotes 
excitotoxicity(21). 
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Table 2. Characteristics of study population (n=7,611) 
 
 Measure Number (%), Mean (95% CI) or 
Median (IQR) 
Antenatal factors  
Gender  
   Male 3,896 (51.2%)  
   Female 3,715 (48.8%) 
Primiparous 4,080 (56.0%) 
Maternal Hypertension 212 (3.0%) 
Non-White Ethnicity 22 (0.3%) 
 
Infants and post-partum factors 
 
Gestational age 39.7 (1.4) 
Birth weight 3472 (484) 
Birth length 51.0 (2.4) 
Birth head circumference 34.9 (1.4) 
Mode of birth  
   Spontaneous cephalic 5,374 (76.1%) 
   Emergency caesarean section 403 (5.7%) 
   Elective caesarean section 290 (4.1%) 
   Instrumental 902 (12.8%) 
   Breech 95 (1.3%) 
Neonatal Sepsis 68 (0.9%) 
  
Birth condition  
Resuscitated 529 (7.5%) 
Apgar score at 1 min 9 (8-9) 
Apgar score at 5 min 10 (9-10) 
Numbers are n(%), median (IQR) or mean (SD) as appropriate
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Table 3. Associations between the three candidate SNPs and measures of birth condition 
SNP Outcome Measure n Homozygous (Wild type) Heterozygous Homozygous (Minor Allele) ptrend 
rs2284411 (C>T)   n=3,147 n=3,504 n=960  
 Resuscitation 7058 228 (7.8%) 244 (7.5%) 57 (6.4%) 0.19 
 Time to Apgar score >6     7053 
    <1 minute  2632 (90.3%) 2945 (90.9%) 821 (91.6%) 0.20 
    1-5 minutes  267 (9.2%) 271 (8.4%) 70 (7.8%)  
    >5 minutes  17 (0.6%) 25 (0.8%) 5 (0.6%)  
 Hypoxic-ischaemic 
Encephalopathy 
7611 12 (0.4%) 13 (0.4%) 4 (0.4%) 0.93 
rs2498804 (C>A)   n=3,726 n=3,182 n=703  
 Resuscitation 7058 250 (7.3%) 222 (7.5%) 57 (8.7%) 0.27 
 Time to Apgar score >6    7053 
    <1 minute  3116 (90.5%) 2690 (91.0%) 592 (90.4%) 0.78 
    1-5 minutes  308 (9.0%) 245 (8.3%) 55 (8.4%)  
    >5 minutes  19 (0.6%) 20 (0.7%) 8 (1.2%)  
 Hypoxic-ischaemic 
Encephalopathy 
7611 13 (0.4%) 14 (0.4%) 3 (0.4%) 0.67 
rs1835740 (A>G)   n=4,615 n=2,642 n=354  
 Resuscitation 7058 301 (7.0%) 198 (8.1%) 30 (9.2%) 0.04 
 Time to Apgar score >6    7053 
    <1 minute  3917 (91.3%) 2193 (90.1%) 288 (88.1%) 0.02 
    1-5 minutes  345 (8.0%) 228 (9.4%) 35 (10.7%)  
    >5 minutes  29 (0.7%) 14 (0.6%) 4 (1.2%)  
 Hypoxic-ischaemic 
Encephalopathy 
7611 18 (0.4%) 10 (0.4%) 1 (0.3%) 0.81 
Values are number (%)
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Table 4.  Logistic regression models for the association between the three 
candidate SNPs and measures of birth condition, for each increasing allele. 
SNP Resuscitation Time to Apgar score 
>6 
Hypoxic-ischaemic 
Encephalopathy 
 OR (95% CI) OR (95% CI) OR (95% CI) 
rs2284411 0.92 (0.80 to 1.05) 0.92 (0.82 to 1.04) 1.02 (0.60 to 1.76) 
rs2498804 1.08 (0.94 to 1.23) 0.98 (0.87 to 1.11) 1.13 (0.65 to 1.95) 
rs1835740 1.17 (1.01 to 1.35) 1.17 (1.03 to 1.34) 0.92 (0.49 to 1.75) 
Values are OR (95% CI) 
 
 
 
 
Table 5. Logistic regression models for the association between the three 
candidate SNPs and the need for resuscitation, for each increasing allele.  
SNP Unadjusted Adjusted for 
antenatal* factors 
Adjusted for antenatal* 
and Intrapartum** 
factors 
 OR (95% CI) OR (95% CI) OR (95% CI) 
rs2284411 0.92 (0.80 to 1.05) 0.91 (0.79 to 1.04) 0.91 (0.79 to 1.06) 
rs2498804 1.08 (0.94 to 1.23) 1.09 (0.95 to 1.25) 1.09 (0.94 to 1.26) 
rs1835740 1.17 (1.01 to 1.35) 1.17 (1.01 to 1.36) 1.18 (1.00 to 1.38) 
* Adjusted for gender, parity and maternal hypertension 
** Adjusted for gestational age, birth weight, length and head circumference, mode of 
birth and neonatal sepsis 
Values are OR (95% CI) 
 
